Millennium Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3,733
| Closed | -$32.1K | – | 4766 |
|
2024
Q1 | $32.1K | Sell |
3,733
-5,840
| -61% | -$50.2K | ﹤0.01% | 3940 |
|
2023
Q4 | $33.5K | Buy |
+9,573
| New | +$33.5K | ﹤0.01% | 3851 |
|
2023
Q3 | – | Sell |
-1,058
| Closed | -$6.16K | – | 4844 |
|
2023
Q2 | $6.16K | Buy |
1,058
+470
| +80% | +$2.74K | ﹤0.01% | 4122 |
|
2023
Q1 | $22K | Buy |
+588
| New | +$22K | ﹤0.01% | 4322 |
|
2022
Q4 | – | Sell |
-1,720
| Closed | -$57K | – | 5517 |
|
2022
Q3 | $57K | Sell |
1,720
-2,041
| -54% | -$67.6K | ﹤0.01% | 4815 |
|
2022
Q2 | $150K | Buy |
+3,761
| New | +$150K | ﹤0.01% | 4571 |
|
2021
Q4 | – | Sell |
-6,974
| Closed | -$540K | – | 5781 |
|
2021
Q3 | $540K | Buy |
+6,974
| New | +$540K | ﹤0.01% | 4116 |
|
2021
Q2 | – | Sell |
-2,590
| Closed | -$426K | – | 5472 |
|
2021
Q1 | $426K | Sell |
2,590
-4,865
| -65% | -$800K | ﹤0.01% | 3750 |
|
2020
Q4 | $1.74M | Buy |
7,455
+3,997
| +116% | +$935K | ﹤0.01% | 2590 |
|
2020
Q3 | $358 | Sell |
3,458
-131
| -4% | -$14 | ﹤0.01% | 2988 |
|
2020
Q2 | $141K | Buy |
3,589
+2,143
| +148% | +$84.2K | ﹤0.01% | 3197 |
|
2020
Q1 | $48K | Buy |
+1,446
| New | +$48K | ﹤0.01% | 2992 |
|
2018
Q4 | – | Sell |
-372
| Closed | -$152K | – | 3776 |
|
2018
Q3 | $152K | Sell |
372
-120
| -24% | -$49K | ﹤0.01% | 3296 |
|
2018
Q2 | $266K | Buy |
492
+309
| +169% | +$167K | ﹤0.01% | 3077 |
|
2018
Q1 | $84K | Buy |
183
+52
| +40% | +$23.9K | ﹤0.01% | 3258 |
|
2017
Q4 | $88K | Buy |
131
+72
| +122% | +$48.4K | ﹤0.01% | 3444 |
|
2017
Q3 | $37K | Buy |
+59
| New | +$37K | ﹤0.01% | 3164 |
|
2015
Q2 | – | Sell |
-132
| Closed | -$372K | – | 3473 |
|
2015
Q1 | $372K | Buy |
+132
| New | +$372K | ﹤0.01% | 2601 |
|